Table 2.
Characteristic | model 1 | model 2 | model 3 | ||||||
---|---|---|---|---|---|---|---|---|---|
OR1 | 95% CI | P-value | OR1 | 95% CI | P-value | OR1 | 95% CI | P-value | |
Continuous | 1.28 | 1.17, 1.40 | < 0.001 | 1.23 | 1.12, 1.36 | < 0.001 | 1.23 | 1.10, 1.39 | < 0.001 |
TyG index | |||||||||
Q1 | — | — | — | — | — | — | |||
Q2 | 1.12 | 0.92, 1.35 | 0.3 | 1.08 | 0.89, 1.31 | 0.4 | 1.10 | 0.91, 1.35 | 0.3 |
Q3 | 1.18 | 0.98, 1.43 | 0.086 | 1.12 | 0.92, 1.36 | 0.3 | 1.13 | 0.91, 1.39 | 0.3 |
Q4 | 1.52 | 1.26, 1.84 | < 0.001 | 1.42 | 1.16, 1.74 | 0.001 | 1.42 | 1.14, 1.77 | 0.002 |
P for trend | < 0.001 | < 0.001 | < 0.001 |
OR: odds ratio, CI: confidence interval
Model 1: Unadjusted
Model 2: Adjusted for age, sex, and BMI
Model 3: Adjusted for age, sex, BMI, race, education, smoking status, total cholesterol, hypertension, heart failure, coronary heart disease, angina, heart attack, stroke, antihyperlipidemic agents, and antidiabetic agents